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Abstract
Introduction: Severe sepsis is associated with high levels of morbidity and mortality, placing a high burden on
healthcare resources. We aimed to study outcomes in the five years after severe sepsis.
Methods: This was a cohort study using data from a prospective audit in 26 adult ICUs in Scotland. Mortality was
measured using clinical databases and quality of life using Short Form 36 (SF-36) at 3.5 and 5 years after severe
sepsis.
Results: A total of 439 patients were recruited with a 58% mortality at 3.5 years and 61% mortality at 5 years. A
total of 85 and 67 patients responded at 3.5 and 5 years follow-up, respectively. SF-36 physical component score
(PCS) was low compared to population controls at 3.5 years (mean 41.8 (SD 11.8)) and at 5 years (mean 44.8 (SD
12.7)). SF-36 mental component score (MCS) was slightly lower than population controls at 3.5 years (mean 47.7
(SD 14.6)) and at 5 years after severe sepsis (mean 48.8 (SD 12.6)). The majority of patients were satisfied with their
current quality of life (QOL) (80%) and all patients would be willing to be treated in an ICU again if they become
critically ill despite many having unpleasant memories (19%) and recall (29%) of ICU events.
Conclusions: Patients with severe sepsis have a high ongoing mortality after severe sepsis. They also have a
significantly lower physical QOL compared to population norms but mental QOL scores were only slightly below
population norms up to five years after severe sepsis. All survivors would be willing to be treated in an ICU again if
critically ill. Mortality and QOL outcomes were broadly similar to other critically ill cohorts throughout the five years
of follow-up.
Introduction
Severe sepsis is an increasingly common condition that is
associated with high levels of morbidity and mortality as
well as placing a large burden upon healthcare resources
throughout the world [1-4]. The morbidity and mortality
from sepsis remain high [2-4]. For those who survive
severe sepsis, many will develop complications associated
with significant long-term sequelae [5-11]. Perhaps unsur-
prisingly, health related quality of life (QOL) and activities
of daily living (ADL) are frequently significantly dimin-
ished [5-12].
QOL is a very important outcome for patients after criti-
cal care and has been shown to be poor in all subgroups of
critical illness compared to the general population at var-
ious time points [13-16]. Poor QOL leads to poor patient
satisfaction and high health care resource utilization
[17,18]. There has been little work following up patients
with severe sepsis for mortality beyond three years and no
work looking at changes in QOL over a five-year period.
Only one study looking at ADL has followed up such
patients for functional outcomes to this time point [9].
The aim of this study was to determine the mortality
and QOL in patients in the five years after severe sepsis.
As secondary outcomes of interest, we also wanted to
study the patients’ willingness to be treated in an ICU
again if they become critically ill, the nature of their mem-
ories of the ICU, their satisfaction with their current QOL
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and the impact of the index illness on their place of resi-
dence and employment status.
Materials and methods
This was a prospective cohort study of patients with severe
sepsis with ethics approval granted by the Scottish multi-
center research ethics committee and informed consent
obtained from all patients’ quality of life follow-up after
three years. The ethics committee approval required the
research team to make contact with patients indirectly
through their parent hospital team, and first and only if
the patients agreed, could the research team contact the
patient. Mortality follow-up used national registry data-
bases which are known to have an accuracy of 99%.
Cohort and data collection
The study was of a prospective cohort of patients with
severe sepsis collected between April and October 2003.
Patients were identified as having: a.) evidence of three of
four systemic inflammatory response syndrome (SIRS) cri-
teria within the previous 24 hours, b.) confirmed or clini-
cally strongly suspected infection, c.) two or more sepsis
induced organ failures of less than 24 hours duration [19],
and d.) an Acute Physiology and Chronic Health Evalua-
tion (APACHE II) score greater than or equal to 25 based
within 24 hours. Inclusion criteria were the criteria for
activated protein C administration at the time of the study
[20]. Data were collected in all 26 general adult ICUs in
Scotland during the study period. Hospital mortality, ICU
mortality, ICU length of stay and hospital length of stay
were obtained from clinical ICU databases.
QOL measures and outcomes
Patients completed Short Form-36 (SF-36) questionnaires
and euroQOL-5D (EQ-5D) by telephone survey at 3.5 and
5 years after ICU admission and the results were calcu-
lated using standard techniques [13-16,21,22]. No data
points were omitted from these surveys. QOL data were
presented as standard deviations as appropriate. SF-36
mental component scores (MCS) and physical component
scores (PCS) were calculated using standard methods and
are presented on a normalized scale with 50 being the
population norm and one standard deviation representing
10 points. The co-primary outcomes were mortality and
QOL at five years. Secondary outcome measures included
QOL at 3.5 years after ICU discharge; ICU, hospital and
3.5 year mortality; ICU length of stay and hospital length
of stay. Questions related to other aspects of their ICU
experience, satisfaction with QOL and changes in employ-
ment status were also asked.
Statistical analysis
Data are presented as numbers and percentages, means
and standard deviations or median and interquartile
ranges as appropriate. For baseline sepsis and ICU data,
numbers and percentages or median and interquartile
ranges were calculated as appropriate. Differences in qual-
ity of life between 3.5 years and 5 years were compared
using paired-tests.
Role of the funding source
The study sponsor and funding sources had no role in
the collection, analysis and interpretation of data; in the
writing of the report; and in the decision to submit the
paper for publication.
Results
The flow of patients through the study is presented in
Figure 1. Mortality follow-up was complete. The baseline,
ICU and hospital characteristics for all groups are pre-
sented in Table 1. In summary of these data, the cohort
had a median age of 58 (45 to 67), a high severity of illness
(APACHE II = 23 (17 to 28); Simplified Acute Physiology
Score (SAPS II) = 41 (30 to 54)) and a low level of chronic
comorbidities (median 0 (0 to 0). The subjects were 53%
male and had a range of organ system dysfunctions with
respiratory failure being most common (65%). Infection
was microbiologically confirmed in 35% of cases, with
bronchopulmonary infection the most common source
(48%), followed by other infections (21%) and blood infec-
tions (14%). Gram positive infection made up 16% and
Gram negative infection (10%) of proven infections.
Further data related to the severity, site and nature of sep-
sis are presented in Table 2.
Figure 1 Participant flow diagram.
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The survival data show that 267 patients (63%) survived
to leave the ICU, 249 (57%) survived to leave the hospital,
185 (42%) survived to 3.5 years and 172 (39%) survived to
5 years (Figure 2). Loss to follow-up occurred in 79/494
(16%) patients. Of the 185 survivors at 3.5 years, 28 with-
drew and 72 were lost to follow-up, leaving 85 responders.
Of the 172 survivors at five years, 26 withdrew and
78 were lost to follow-up, leaving 67 responders.
Table 3 shows the QOL outcomes including EQ-5D and
SF-36 domains and component scores. EQ-5D scores are
0.64 (SD 0.36) at 3.5 years and 0.68 (SD 0.32) at 5 years.
SF-36 PCS is lower than population controls at 41.8 (SD
11.8) at 3.5 years and 44.8 (SD 12.7) at 5 years. SF-36
MCS is 47.7 (SD 14.6) at 3.5 years and 48.8 (SD 12.6) at
5 years.
At five years, the SF-36 PCS of 44.8 is significantly
lower than the mean population norm of 50 (P = 0.001).
The equivalent comparison for the mental component
at five years shows no significant difference (P = 0.453).
At five years all patients stated they would be willing to
be treated in an ICU again if they become critically ill, 19%
had unpleasant memories of ICU events, 80% were either
very happy or mostly happy with their current QOL, with
75% either working less or not working at all compared to
before their critical illness (see Table 4).
Discussion
This cohort study was designed to study mortality and
QOL in the five years after ICU admission for severe sep-
sis and demonstrates a high mortality in this cohort of
patients at this time point. The majority of this mortality
occurs in hospital and within the first year but there is an
ongoing attrition over the entire five-year period. This
attrition has been demonstrated in other general ICU
cohorts, but in sepsis cohorts follow-up has not previously
been over such a long time period [14,15,23]. This study
also demonstrates poor physical QOL scores in sepsis
patients compared to age- and sex-matched population
controls at 3.5 and 5 years. The QOL scores in this cohort
are broadly similar to QOL scores up to five years in other
cohorts of critically ill cohorts [14,15,17,24]. As has been
previously demonstrated in other critically ill cohorts,
mental QOL is only slightly below the age- and sex-
matched population control level [12,14,15,17,24]. All our
patients stated they would be willing to be treated in an
ICU again if they become critically ill.
Table 1 Baseline, intensive care and hospital
characteristics of study patients.
All cases N = 439
Median 25th 75th
Age 58.0 45.0 67.0
SAPS II score 41.0 30.0 54.0
SAPS II predicted mortality 26.6 10.6 55.3
APACHE II score 23.0 17.0 28.0
APACHE II predictive mortality 46.0 23.6 66.5
Number of APACHE II comorbidities
(median, IQR)
0 0 0
Number of APACHE II comorbidities
(mean, SD)
0.2 0.5
Length of hospital stay prior to ICU 1 0 3
ICU length of stay (all comers) 7.1 2.7 15.8
ICU length of stay (ICU survivors,
n = 277)
8.8 3.9 17.9
ICU length of stay (ICU non-survivors,
n = 162)
3.9 1.3 118
Hospital length of stay 19.0 8.0 41.2
n %
Sex (male) 234 53%
Readmission to ICU 9 2%
Cardiovascular dysfunction 237 54%
Respiratory dysfunction 282 65%
Renal dysfunction 166 38%
Metabolic acidosis 195 45%
Haematological dysfunction 100 23%
APACHE II system failure
Respiratory 138 31%
Cardiovascular 124 28%
Neurological 44 10%
Gastrointestinal 93 21%
Other 26 7%
Unknown 14 3%
Activated protein C administration 94 21%
Data presented as medians and 25th and 75th centiles or as number and
percentages as appropriate.
Table 2 Data on severity, site and nature of sepsis for
study patients
All patients N = 439
n %
APACHE II diagnosis of sepsis 72 16%
Microbiologically confirmed infection 155 35%
Site of infection
Blood/bacteraemia 63 14%
Bronchopulmonary 211 48%
Deep wound 43 10%
Urinary 16 4%
Other 91 21%
Unknown 15 3%
Nature of infection
Bacterial - Gram positive 69 16%
Bacterial - Gram negative 42 10%
Mixed 35 8%
Fungal 6 1%
Viral 7 2%
Unknown 280 64%
Data presented as numbers and percentages.
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In a landmark study, Quartin et al. followed up survi-
vors of severe sepsis for eight years and showed an
excess mortality compared to population controls [11].
Other studies have looked at survival in severe sepsis
subgroups, such as community-acquired pneumonia, but
find the same pattern in excess long-term mortality
[25-27]. A post-hoc follow-up of patients from the PRO-
WESS (Recombinant Human Activated Protein C
Worldwide Evaluation in Severe Sepsis) study showed
that the reduction in mortality seen at 28 days was lost
after hospital discharge through to 3.6 years although
most patients in this study were followed up for shorter
durations [28]. When we compare five-year mortality
data for this group, we can look at results from general
ICU [14,15,24,29] or acute respiratory distress syndrome
(ARDS) patients [17]. All these studies demonstrate an
ongoing attrition in these cohorts with time compared to
age- and sex-matched population cohorts. These results
seem broadly similar to severe sepsis mortality outcomes
although the younger age on ICU admission in our cohort
may explain the slightly lower than expected mortality
rates between 3.5 and 5 years [9,11,25-27].
There have been a few papers looking at differences in
QOL outcomes in severe sepsis patients. A study by Hey-
land et al. suggested that SF-36 QOL scores were lower
than the general population and that SF-36 had a good
reliability and validity in this group [10]. A study by
Hofhuis et al. showed poor QOL scores at six months
after an ICU stay compared to age- and sex-matched con-
trols [5]. A study by Granja et al. also found poor QOL in
survivors of sepsis that was comparable to other non-sep-
tic critical illness survivors [30]. A study by Longo et al.
studied patients receiving activated protein C compared to
unmatched controls and looked at mortality and QOL
outcome up to seven months after ICU discharge [31].
They found an 11.8% absolute risk reduction for mortality
in the activated protein C patients at seven months and
improvements in a variety of QOL scores. This study was
limited by small sample size and the lack of matching.
Further studies have looked at ADL in severe sepsis survi-
vors [9]. This study demonstrated that many severe sepsis
patients have poor levels of activity (measured by ADL) in
the period before severe sepsis and go on to have further
functional disability in the five years after sepsis but not all
of these patients are admitted to an ICU during their ill-
ness. The exact relationship between ADL and physical
QOL in severe sepsis survivors is not fully understood but
the information we elucidate from these metrics are likely
to overlap to some degree.
The current study focuses on QOL outcomes up to five
years after severe sepsis. There are no studies we have
identified that studied QOL in severe sepsis patients for
Table 3 Quality of life outcomes for severe sepsis at 3.5 and 5 years
QOL metric 3.5 years 5 years Comparison between 3.5 and 5 years
N Mean SD N Mean SD N Mean 95% C.I. P-value
EQ-5D 83 0.64 0.36 66 0.68 0.32 64 0.02 (-0.04, 0.07) 0.546
SF-36 PCS 82 41.8 11.8 62 44.8 12.7 61 0.3 (-2.4, 3) 0.818
SF-36 MCS 82 47.7 14.6 62 48.8 12.6 61 2.4 (0.5, 4.2) 0.014
Physical Functioning 85 37.5 14.5 67 40.9 15.1 67 2.9 (0.9, 4.9) 0.005
Role Physical 84 41.7 13.5 66 44.6 13.7 65 2.5 (-0.1, 5.1) 0.057
Bodily Pain 84 48.0 12.8 65 49.9 11.9 64 1.1 (-1, 3.2) 0.284
General Health 84 43.6 13.3 65 45.7 13.3 64 1.2 (-0.7, 3.1) 0.206
Vitality 85 46.2 12.2 67 45.8 12.4 67 -1.0 (-3.3, 1.3) 0.380
Social Functioning 84 44.9 13.6 67 44.8 14.2 66 -0.1 (-2.2, 2) 0.938
Role Emotional 83 43.4 16.2 66 46.8 14.6 65 2.7 (-0.9, 6.2) 0.135
Mental Health 85 47.0 13.8 67 47.6 13.2 67 0.3 (-1.8, 2.5) 0.764
CI, confidence interval; MCS, mental component score; N, number; PCS, physical component score; SD, standard deviation; SF-36, short form 36.
Figure 2 Kaplan-Meier survival estimates for the entire cohort.
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this long a time period. The most comparable studies are
ones of general ICU cohorts [14,15,24] and of ARDS
patients [17]. Broadly, these QOL scores are similar to
those of other critically ill cohorts over this long follow-
up [30]. It is interesting to note that the mental QOL
scores are only slightly below the age- and sex-matched
population control levels, which seems at odds with
papers suggesting high levels of psychological morbidity
and cognitive dysfunction after critical illness [9,12,
15,17,24,32-35]. This may suggest a problem with the
sensitivity or calibration of the SF-36 MCS in patients
after critical illness since reports of depression, anxiety
and post-traumatic stress disorders after severe sepsis
and other critical illness seem so consistent [15,34-38].
Clearly, cognitive dysfunction is not measured in the SF-
36 MCS per se but it may confound the measurement of
both mental and physical QOL scores.
It was very interesting to find that all our patients would
be willing to undergo treatment in an ICU again if they
become critically ill despite generally poor physical QOL
scores and 19 to 29% having either unpleasant recall or
memories of their ICU stay [37,39,40]. Despite the rela-
tively poor QOL scores, the vast majority (80%) of patients
reported they were mostly or very happy with their current
QOL [41]. Of course, there could be a cognitive bias in
these responses as it must be difficult to state you would
not want life saving treatments or that you have a poor
QOL. These data also seem to somewhat contradict the
Table 4 Other study outcomes
3.5 years 5 years
Would you be willing to be treated in an ICU again? Valid N = 74 Valid N = 57
Yes 74 100% 57 100%
No 0 0% 0 0%
Do you have unpleasant recall of ICU events? Valid N = 84 Valid N = 66
Yes 26 31% 19 29%
No 58 69% 47 71%
Do you have unpleasant memories of ICU events? Valid N = 84 Valid N = 67
Yes 12 14% 13 19%
No 72 86% 54 81%
How do you rate your satisfaction with your current QOL? Valid N = 84 Valid N = 67
Very happy 16 19% 13 19%
Mostly happy 51 61% 41 61%
Often unhappy 13 15% 12 18%
Very unhappy 4 5% 1 1%
What is your current place of residence? Valid N = 79 Valid N = 63
Private home without assistance 62 79% 49 78%
Private home with assistance 16 20% 12 19%
Sheltered housing 0 0% 2 3%
Care home 1 1% 0 0%
Other 0 0% 0 0%
What is your current employment status? Valid N = 66 Valid N = 55
Full time employment / studies 19 29% 14 25%
Part time employment / studies 4 6% 5 9%
Occasional employment 0 0% 0 0%
Retired 29 44% 24 44%
Unemployed 12 18% 11 20%
Long term disability 2 3% 1 2%
Has your employment status changed since your illness? Valid N = 84 Valid N = 65
Yes 19 23% 12 18%
No 65 77% 53 82%
If you were employed before your ICU admission, what is the intensity of
your current employment compared to before your illness?
Valid N = 62 Valid N = 58
I work more 14 13% 7 0%
No difference 14 13% 15 25%
I work less 25 67% 24 50%
I am not working 9 7% 12 25%
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results of previous work in acutely ill patients [40]. With
regard to employment status, 34% were in full time
employment at five years with 75% stating they now work
less or are now not working, since their illness [17,18,32].
Although it must be identified that some of this reduction
in employment is due to retirements. This change in
employment status speaks to the broad long-term financial
impact of severe sepsis on patients and their families
[15,18,42].
This study has a number of strengths and limitations
that need to be considered. Strengths include the multi-
center nature of the data and the fact that all adult gen-
eral ICUs in one country were included. Further
strengths include the prolonged follow-up period that
has not been attained in previous studies. Compared to
previous studies in this field, this is a reasonable sized
study, but from an epidemiological perspective the lim-
ited patient number reduces the ability to make strong
conclusions about this cohort. Limitations include the
loss to follow-up in this study. The cohorts were not
approached for consent for long term follow-up until
well after their index ICU admission, thus denying us
shorter term QOL data. The ethics committee approval
required the research team to make contact with patients
indirectly through their parent hospital team first and
only if the patients agreed could the research team con-
tact the patient. We believe that this additional step led
to a significantly lower recruitment and retention to the
study than a direct approach would have achieved. This
has the potential to introduce a recruitment bias into the
study data collection, although we are unable to identify
the magnitude of direction of such a bias. Since it is likely
that poor QOL is more common in those patients who
die during follow-up, there is likely excess QOL loss to
follow-up in the highest risk patients and, therefore,
these QOL results may, on average, be better than those
actually experienced by the patients. This issue is stan-
dard to all studies using prospective cohort designs. With
regard to the generalizability of the results, we recruited
patients from all adult ICU patients in one country which
enhances the generalizability but we only recruited
patients with an APACHE II score ≥25 making this a
sicker cohort than in some studies of severe sepsis. It is
noted that despite the inclusion criteria for this cohort
being APACHE II ≥25, some patients with lower
APACHE II scores were recruited to the study. In this
study we demonstrated that 35% of infections were
microbiologically confirmed compared to those in Eur-
opean Prevalence of Infection in Intensive Care (EPIC)
and 60% in Sepsis Occurrence in Acutely Ill Patients
(SOAP) studies [43,44]. A further limitation is the lack of
pre-morbid data on physical or psychological morbidity
and function [9,34,45]. Recent studies have identified the
high level of pre-morbid physical, psychological and
cognitive dysfunction in this group and that levels of
these morbidities may not always be significantly higher
than in the post-morbid recovery phase of critical illness
[9,34,45]. We are, therefore, unable to confidently deter-
mine the acuity of these symptoms or their relationship
to the current levels of dysfunction to the index illness in
our patient group. Finally, it has been suggested by one
author that QOL data should be adjusted for pre-morbid
conditions, we did not do this as we believe that this is
not an accepted methodological standard for QOL mea-
surement [46].
Conclusions
Patients with severe sepsis have a high ongoing mortality
after severe sepsis with only 61% surviving five years. They
also have a significantly lower physical QOL compared to
the population norm but mental QOL scores were only
slightly below population norms up to five years after
severe sepsis. Mortality and QOL outcomes were broadly
similar to other critically ill cohorts throughout the five
years of follow-up. These data need to be considered when
evaluating longer-term outcomes and when considering
the cost-effectiveness of care in this patient group.
Key messages
• Sepsis is known to have a high, shorter-term mortality;
this high mortality seems to continue for up to five
years after severe sepsis.
• Quality of life is known to be poor in the years after
critical care admission and we have demonstrated simi-
lar patterns of QOL deficit after severe sepsis.
• The majority of severe sepsis survivors were satisfied
with their current QOL and all patients would be willing
to be treated in an ICU again if they become critically ill
despite many having unpleasant memories and recall of
ICU events.
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